vs
AMERICAS CARMART INC（CRMT）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
AMERICAS CARMART INC的季度营收约是Ultragenyx Pharmaceutical Inc.的1.4倍（$286.3M vs $207.3M），AMERICAS CARMART INC净利率更高（-7.8% vs -62.0%，领先54.2%），Ultragenyx Pharmaceutical Inc.同比增速更快（25.9% vs 0.2%），AMERICAS CARMART INC自由现金流更多（$8.3M vs $-100.8M），过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高（38.0% vs 9.1%）
Americas CarMart Inc是美国专业汽车零售商，主要销售二手车，为信用记录有限或信用不佳的客户提供定制化内部融资方案，其线下门店网络集中在美国南部和中西部地区，服务购车市场中需求未被充分覆盖的消费群体。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
CRMT vs RARE — 直观对比
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $286.3M | $207.3M |
| 净利润 | $-22.5M | $-128.6M |
| 毛利率 | 37.5% | — |
| 营业利润率 | -9.6% | -54.7% |
| 净利率 | -7.8% | -62.0% |
| 营收同比 | 0.2% | 25.9% |
| 净利润同比 | -540.7% | 3.5% |
| 每股收益（稀释后） | $-2.71 | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $286.3M | $207.3M | ||
| Q3 25 | $276.2M | $159.9M | ||
| Q2 25 | $309.7M | $166.5M | ||
| Q1 25 | $263.5M | $139.3M | ||
| Q4 24 | $285.8M | $164.6M | ||
| Q3 24 | $287.2M | $139.5M | ||
| Q2 24 | $309.7M | $147.0M | ||
| Q1 24 | $240.4M | $108.8M |
| Q4 25 | $-22.5M | $-128.6M | ||
| Q3 25 | $-5.7M | $-180.4M | ||
| Q2 25 | $10.6M | $-115.0M | ||
| Q1 25 | $3.2M | $-151.1M | ||
| Q4 24 | $5.1M | $-133.2M | ||
| Q3 24 | $-964.0K | $-133.5M | ||
| Q2 24 | $426.0K | $-131.6M | ||
| Q1 24 | $-8.5M | $-170.7M |
| Q4 25 | 37.5% | — | ||
| Q3 25 | 36.6% | — | ||
| Q2 25 | 36.4% | — | ||
| Q1 25 | 35.7% | — | ||
| Q4 24 | 39.4% | — | ||
| Q3 24 | 35.0% | — | ||
| Q2 24 | 35.1% | — | ||
| Q1 24 | 34.2% | — |
| Q4 25 | -9.6% | -54.7% | ||
| Q3 25 | -2.7% | -106.9% | ||
| Q2 25 | 4.0% | -64.8% | ||
| Q1 25 | 1.7% | -102.6% | ||
| Q4 24 | 2.5% | -74.3% | ||
| Q3 24 | -0.4% | -94.6% | ||
| Q2 24 | — | -79.1% | ||
| Q1 24 | -4.3% | -151.9% |
| Q4 25 | -7.8% | -62.0% | ||
| Q3 25 | -2.1% | -112.8% | ||
| Q2 25 | 3.4% | -69.0% | ||
| Q1 25 | 1.2% | -108.5% | ||
| Q4 24 | 1.8% | -80.9% | ||
| Q3 24 | -0.3% | -95.7% | ||
| Q2 24 | 0.1% | -89.5% | ||
| Q1 24 | -3.6% | -156.8% |
| Q4 25 | $-2.71 | $-1.28 | ||
| Q3 25 | $-0.69 | $-1.81 | ||
| Q2 25 | $1.50 | $-1.17 | ||
| Q1 25 | $0.37 | $-1.57 | ||
| Q4 24 | $0.61 | $-1.34 | ||
| Q3 24 | $-0.15 | $-1.40 | ||
| Q2 24 | $0.09 | $-1.52 | ||
| Q1 24 | $-1.34 | $-2.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $122.4M | $421.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $555.0M | $-80.0M |
| 总资产 | $1.7B | $1.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q4 25 | $122.4M | $421.0M | ||
| Q3 25 | $9.7M | $202.5M | ||
| Q2 25 | $9.8M | $176.3M | ||
| Q1 25 | $8.5M | $127.1M | ||
| Q4 24 | $8.0M | $174.0M | ||
| Q3 24 | $4.7M | $150.6M | ||
| Q2 24 | $5.5M | $480.7M | ||
| Q1 24 | $4.2M | $112.3M |
| Q4 25 | $555.0M | $-80.0M | ||
| Q3 25 | $564.8M | $9.2M | ||
| Q2 25 | $569.4M | $151.3M | ||
| Q1 25 | $557.8M | $144.2M | ||
| Q4 24 | $553.6M | $255.0M | ||
| Q3 24 | $471.1M | $346.8M | ||
| Q2 24 | $470.6M | $432.4M | ||
| Q1 24 | $468.9M | $140.3M |
| Q4 25 | $1.7B | $1.5B | ||
| Q3 25 | $1.6B | $1.2B | ||
| Q2 25 | $1.6B | $1.3B | ||
| Q1 25 | $1.6B | $1.3B | ||
| Q4 24 | $1.6B | $1.5B | ||
| Q3 24 | $1.5B | $1.5B | ||
| Q2 24 | $1.5B | $1.6B | ||
| Q1 24 | $1.5B | $1.3B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $9.1M | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | $8.3M | $-100.8M |
| 自由现金流率自由现金流/营收 | 2.9% | -48.6% |
| 资本支出强度资本支出/营收 | 0.3% | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-11.2M | $-472.0M |
8季度趋势，按日历期对齐
| Q4 25 | $9.1M | $-99.8M | ||
| Q3 25 | $-5.9M | $-91.4M | ||
| Q2 25 | $19.2M | $-108.3M | ||
| Q1 25 | $-30.8M | $-166.5M | ||
| Q4 24 | $-22.2M | $-79.3M | ||
| Q3 24 | $-15.0M | $-67.0M | ||
| Q2 24 | $-10.7M | $-77.0M | ||
| Q1 24 | $13.0M | $-190.7M |
| Q4 25 | $8.3M | $-100.8M | ||
| Q3 25 | $-6.4M | $-92.7M | ||
| Q2 25 | $18.4M | $-110.7M | ||
| Q1 25 | $-31.5M | $-167.8M | ||
| Q4 24 | $-23.6M | $-79.5M | ||
| Q3 24 | $-16.0M | $-68.6M | ||
| Q2 24 | $-12.0M | $-79.0M | ||
| Q1 24 | $10.2M | $-193.9M |
| Q4 25 | 2.9% | -48.6% | ||
| Q3 25 | -2.3% | -58.0% | ||
| Q2 25 | 5.9% | -66.5% | ||
| Q1 25 | -12.0% | -120.5% | ||
| Q4 24 | -8.3% | -48.3% | ||
| Q3 24 | -5.6% | -49.2% | ||
| Q2 24 | -3.9% | -53.7% | ||
| Q1 24 | 4.3% | -178.2% |
| Q4 25 | 0.3% | 0.5% | ||
| Q3 25 | 0.2% | 0.8% | ||
| Q2 25 | 0.3% | 1.5% | ||
| Q1 25 | 0.3% | 1.0% | ||
| Q4 24 | 0.5% | 0.1% | ||
| Q3 24 | 0.3% | 1.2% | ||
| Q2 24 | 0.4% | 1.4% | ||
| Q1 24 | 1.1% | 3.0% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 1.81× | — | ||
| Q1 25 | -9.73× | — | ||
| Q4 24 | -4.36× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -25.18× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CRMT
| Sales Used Autos | $241.4M | 84% |
| Service Contract Sales | $23.6M | 8% |
| Wholesales Third Party | $12.6M | 4% |
| Payment Protection Plan Revenue | $8.7M | 3% |
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
